These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 26350893)

  • 1. Polypharmacy, the Elderly, and Deprescribing.
    Jetha S
    Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and prevalence of adverse drug events caused by potentially inappropriate medication in homebound elderly patients: a retrospective study using a nationwide survey in Japan.
    Onda M; Imai H; Takada Y; Fujii S; Shono T; Nanaumi Y
    BMJ Open; 2015 Aug; 5(8):e007581. PubMed ID: 26260347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using two tools to identify Potentially Inappropriate Medications (PIM) in elderly patients in Southern Chile.
    Arellano C; Saldivia G; Córdova P; Fernández P; Morales F; López M; Villa L
    Arch Gerontol Geriatr; 2016; 67():139-44. PubMed ID: 27504710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
    Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
    Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians need to take the lead in deprescribing.
    Scott IA; Le Couteur DG
    Intern Med J; 2015 Mar; 45(3):352-6. PubMed ID: 25735580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.
    Nightingale G; Hajjar E; Swartz K; Andrel-Sendecki J; Chapman A
    J Clin Oncol; 2015 May; 33(13):1453-9. PubMed ID: 25800766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical Outcome.
    Van der Linden L; Decoutere L; Walgraeve K; Milisen K; Flamaing J; Spriet I; Tournoy J
    Drugs Aging; 2017 Feb; 34(2):123-133. PubMed ID: 27915457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of medication reviews by community pharmacists.
    Kolhatkar A; Cheng L; Chan FK; Harrison M; Law MR
    J Am Pharm Assoc (2003); 2016; 56(5):513-520.e1. PubMed ID: 27594104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "iatrogenic triad": polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults.
    Novaes PH; da Cruz DT; Lucchetti ALG; Leite ICG; Lucchetti G
    Int J Clin Pharm; 2017 Aug; 39(4):818-825. PubMed ID: 28455830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprescribing: An Application to Medication Management in Older Adults.
    Bemben NM
    Pharmacotherapy; 2016 Jul; 36(7):774-80. PubMed ID: 27263530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stakeholder Perspectives on Factors Related to Deprescribing Potentially Inappropriate Medications in Older Adults Receiving Dialysis.
    Hall RK; Rutledge J; Lucas A; Liu CK; Clair Russell JS; Peter WS; Fish LJ; Colón-Emeric C
    Clin J Am Soc Nephrol; 2023 Oct; 18(10):1310-1320. PubMed ID: 37499693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.
    Galazzi A; Lusignani M; Chiarelli MT; Mannucci PM; Franchi C; Tettamanti M; Reeve E; Nobili A
    Int J Clin Pharm; 2016 Apr; 38(2):454-61. PubMed ID: 26951120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instruments for evaluating medication use and prescribing in older adults.
    Bulloch MN; Olin JL
    J Am Pharm Assoc (2003); 2014; 54(5):530-7. PubMed ID: 25216883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the Beers and STOPP criteria for identifying the use of potentially inappropriate medications among elderly patients in primary care.
    Oliveira MG; Amorim WW; de Jesus SR; Heine JM; Coqueiro HL; Passos LC
    J Eval Clin Pract; 2015 Apr; 21(2):320-5. PubMed ID: 25675971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is my older cancer patient on too many medications?
    Turner JP; Shakib S; Bell JS
    J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician Factors Associated with Polypharmacy and Potentially Inappropriate Medication Use.
    Ie K; Felton M; Springer S; Wilson SA; Albert SM
    J Am Board Fam Med; 2017; 30(4):528-536. PubMed ID: 28720634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
    Palagyi A; Keay L; Harper J; Potter J; Lindley RI
    BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prioritizing interventions to manage polypharmacy in Australian aged care facilities.
    Jokanovic N; Wang KN; Dooley MJ; Lalic S; Tan EC; Kirkpatrick CM; Bell JS
    Res Social Adm Pharm; 2017; 13(3):564-574. PubMed ID: 27374998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients.
    Alkan A; Yaşar A; Karcı E; Köksoy EB; Ürün M; Şenler FÇ; Ürün Y; Tuncay G; Ergün H; Akbulut H
    Support Care Cancer; 2017 Jan; 25(1):229-236. PubMed ID: 27619388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.